NCT02523105

Evaluation of Use of Brain Activity Monitoring for Evaluation of Depression Treatment

Evaluation of Use of Brain Activity Monitoring for Early Identification of Pharmaceutical Treatment Efficacy and Development of Depression Deterioration Events.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 37 (actual)
• Sponsor: Brainmarc Ltd. · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Accepted

Summary

This study evaluates the use of brain activity monitoring for early identification of pharmaceutical treatment efficacy and development of depression deterioration events.

Detailed description

The study will be conducted in two arms: In arm I, participants diagnosed with depression. In arm II, healthy participants. Arm I - Participants that need to start or switch their pharmacological antidepressant therapy will be recruited. Their clinical status will be evaluated and their EEG characteristics will be collected. Arm II - Clinical and EEG characteristics of Healthy volunteers will collected on a similar timetable.

Conditions

• Depression

Interventions

Type	Name	Description
DEVICE	EEG monitoring	EEG evaluation will be done using two off the shelf EEG devices for research and consumer use. The first one is a device called MindWave by NeuroSky ltd (http://neurosky.com) the second called EPOC by Emotiv ltd (https://emotiv.com/epoc.php). EEG evaluation will be conducted for a total duration of 20 minutes with and without auditory stimulation. The auditory stimulation will be performed using standard headphone or earphones to reduce external noises.

Timeline

• Start date: 2015-09-01
• Primary completion: 2016-10-09
• Completion: 2017-01-05
• First posted: 2015-08-14
• Last updated: 2018-04-26

Locations

2 sites across 1 country: Israel